| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/21/2007 | CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 02/21/2007 | CN1915988A Resultant Ruisidilasu from generic delavird and resveratrol, and synthetic method |
| 02/21/2007 | CN1915973A 3 ¿C brommethyl ¿C 2 ¿C trifluoromethyl N -ú¿4 - chloro benzol formacylú®indole and synthetic method |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/20/2007 | US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179833 Hydrogenation catalysts |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/20/2007 | US7179808 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors |
| 02/20/2007 | US7179574 Hydrazone-based charge transport materials |
| 02/20/2007 | CA2404700C Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007018015A1 Indole compound, optical filter and optical recording material |
| 02/15/2007 | WO2007017602A2 Marqueurs, leur procede de fabrication et leurs applications |
| 02/15/2007 | WO2007017289A2 Acyltryptophanols for fertility control |
| 02/15/2007 | WO2007017117A1 Process for the synthesis of rosuvastatin calcium |
| 02/15/2007 | WO2007017087A1 Process for the preparation of crystalline perindopril |
| 02/15/2007 | WO2006125180B1 Piperazine derivatives and their uses as therapeutic agents |
| 02/15/2007 | WO2005092897A3 2,4,6-phenylsubstituted cyclic ketoenoles |
| 02/15/2007 | US20070037867 Antihepatitis c virus agent and anti-hiv agent |
| 02/15/2007 | US20070037854 Process for preparing sulfonamide-containing indole compounds |
| 02/15/2007 | US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists. |
| 02/15/2007 | US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 02/15/2007 | US20070037011 Arylamine compound and synthetic method thereof |
| 02/15/2007 | DE102005038632A1 New acylated tryptophan derivatives, useful for controlling male and female fertility, are antagonists of follicle-stimulating hormone receptor |
| 02/15/2007 | CA2820233A1 Perylenequinone derivatives and uses thereof |
| 02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
| 02/15/2007 | CA2618217A1 Marqueurs, leur procede de fabrication et leurs applications |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | CA2615691A1 Process for the preparation of crystalline perindopril |
| 02/14/2007 | EP1752448A2 Fluvastatin sodium crystal form lxxix, processes for preparing it, compositions containing it and methods of using it |
| 02/14/2007 | EP1752440A1 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751138A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| 02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/14/2007 | EP1751107A1 Process for the preparation of perindopril |
| 02/14/2007 | EP1751106A1 Piperazine derivatives of alkyl oxindoles |
| 02/14/2007 | EP1751105A1 Piperazine derivatives of alkyl oxindoles |
| 02/14/2007 | EP1751104A1 Synthesis methods and intermediates for the manufacture of rizatriptan |
| 02/14/2007 | EP1751103A1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 02/14/2007 | EP1751102A1 Process for producing a dipeptidyl peptidase iv inhibitor |
| 02/14/2007 | EP1751095A1 Substituted cyclohexylcarboxylic acid derivatives |
| 02/14/2007 | EP1751094A2 Beta-peptides |
| 02/14/2007 | EP1751093A1 Substituted cyclohexylacetic acid derivatives |
| 02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1750691A2 Compounds for treatment of aids and other diseases |
| 02/14/2007 | EP1438045B1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | EP0946478B1 Process for the solid phase synthesis of aldehydes, ketones and hydroxamic acid compounds |
| 02/14/2007 | CN1914214A Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease |
| 02/14/2007 | CN1914172A 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 02/14/2007 | CN1914171A Hydroisoindoline tachykinin receptor antagonists |
| 02/14/2007 | CN1914170A Synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 02/14/2007 | CN1911928A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 02/14/2007 | CN1911912A Synthesis method of indole |
| 02/14/2007 | CN1300147C Camptothecin derivatives preparing process |
| 02/14/2007 | CN1300146C Photochromic compound of spiro [indolerin-phenanthroline oxazine and its preparation and use |
| 02/14/2007 | CN1300145C Indole oxazine compound and its synthesis and use |
| 02/14/2007 | CN1300111C Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176231 For example, 5-acetyl-3-{[4-(diethylaminomethyl)-phenylamino]-phenyl-methylidene}-2-indolinone; for treatment of diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alzheimer's disease, stroke, neurotraumatic injuries, bipolar disorders |
| 02/13/2007 | US7176230 For example, N-benzenesulfonyl-3-(5'-hydroxymethyl-2'-furyl)indole; anticoagulants, vasodilators |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/13/2007 | US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2239618C Improved metal-ligand complex catalyzed processes |
| 02/08/2007 | WO2007015824A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | WO2007015805A1 1-amino linked compounds |
| 02/08/2007 | WO2007015407A1 Carbazole derivative, light-emitting element material obtained by using carbazole derivative, light-emitting element, and electronic device |
| 02/08/2007 | WO2007014851A2 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/08/2007 | WO2007014843A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 02/08/2007 | WO2007014687A1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/08/2007 | WO2007014608A1 Quadratic acid ii derivatives |
| 02/08/2007 | WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 02/08/2007 | US20070032661 Process for the preparation of intermediates of perindopril |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032540 By reacting indole-4-carboxaldehyde with nitromethane, reducing the nitro group to form an amine, propylating the amine group, oxidizing the 2 C atom in the indole ring, and optionally forming a salt, especially the hydrochloride |
| 02/08/2007 | US20070032539 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 02/08/2007 | US20070032520 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/08/2007 | US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 02/08/2007 | US20070031701 Carbazole derivative, light-emitting element material obtained by using carbazole derivative, light-emitting element, and electronic device |
| 02/08/2007 | US20070031514 Use of isoindolinone derivatives as insecticides |
| 02/08/2007 | CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/08/2007 | CA2616685A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |